Nyxoah NYXH
NASDAQ NYXH
$1.60 -0.04 (-2.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nyxoah (NYXH) Income from Non-Controlling Interests (2021 - 2024)

Nyxoah (NYXH) posted quarterly Income from Non-Controlling Interests of $594.1 million for Q4 2024, up 1515.91% year-over-year from $36.8 million in Q1 2024, and up 1515.91% quarter-over-quarter from -$42.0 million in Q4 2023.

Nyxoah (NYXH) Income from Non-Controlling Interests (2021 - 2024) Analysis & Trends

Nyxoah's Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at $594.1 million for Q4 2024.

  • In Q4 2024, Income from Non-Controlling Interests rose 1515.91% year-over-year to $594.1 million; the TTM figure through Dec 2024 stood at $637.2 million (changed N/A YoY), while the FY2024 annual figure was $830.3 million, up 2078.71% from the prior year.
  • Income from Non-Controlling Interests for Q4 2024 stood at $594.1 million, up from -$42.0 million in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $594.1 million in Q4 2024, with the low at -$42.0 million in Q4 2023.
  • The 4-year median for Income from Non-Controlling Interests is $42.5 million (2022), against an average of $159.3 million.
  • The sharpest annual moves came in 2023 and 2024: Income from Non-Controlling Interests plunged 242.74% in 2023, then soared 1515.91% in 2024.
  • Nyxoah's Income from Non-Controlling Interests stood at $97.2 million in 2021, then slumped by 112.59% to -$12.2 million in 2022, then slumped by 242.74% to -$42.0 million in 2023, then jumped by 1515.91% to $594.1 million in 2024.
  • Business Quant data shows NYXH's Income from Non-Controlling Interests at $594.1 million in Q4 2024, -$42.0 million in Q4 2023, and -$12.2 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 6.60 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 79.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -
10 Nyxoah 90.94 Mn 90.94 Mn 5.33 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 594.14 Mn
Dec 31, 2023 -41.96 Mn
Dec 31, 2022 -12.24 Mn
Dec 31, 2021 97.24 Mn